| Drug delivery approaches for HuR-targeted therapy for lung cancer R Raguraman, S Shanmugarama, M Mehta, JE Peterson, YD Zhao, ... Advanced drug delivery reviews 180, 114068, 2022 | 14 | 2022 |
| Recent patents on plant-derived nanoparticles and their potential application towards various cancer therapeutics SB Santhosh, S Shanmugarama, N Ramesh, AMS Tharik, ... Recent Patents on Anti-Cancer Drug Discovery 18 (3), 292-306, 2023 | 3 | 2023 |
| Preventing spontaneous cerebral microhemorrhages in aging mice: a novel approach targeting cellular senescence with ABT263/navitoclax J Faakye, Á Nyúl-Tóth, M Muranyi, R Gulej, B Csik, S Shanmugarama, ... GeroScience 46 (1), 21-37, 2024 | 2 | 2024 |
| Endothelial deficiency of insulin‐like growth factor‐1 receptor leads to blood–brain barrier disruption and accelerated endothelial senescence in mice, mimicking aspects of the … R Gulej, B Csik, J Faakye, S Tarantini, S Shanmugarama, SS Chandragiri, ... Microcirculation 31 (2), e12840, 2024 | 1 | 2024 |
| Imaging the time course, morphology, neuronal tissue compression, and resolution of cerebral microhemorrhages in mice using intravital two-photon microscopy: insights into … J Faakye, Á Nyúl-Tóth, R Gulej, B Csik, S Tarantini, S Shanmugarama, ... GeroScience 45 (5), 2851-2872, 2023 | 1 | 2023 |
| Anthocyanins as Immunomodulatory Dietary Supplements: A Nutraceutical Perspective and Micro-/Nano-Strategies for Enhanced Bioavailability TP Ijinu, LF De Lellis, S Shanmugarama, R Pérez-Gregorio, P Sasikumar, ... Nutrients 15 (19), 4152, 2023 | 1 | 2023 |
| ALK protein expression and its prognostic significance in MYCN non amplified neuroblastoma N Aravindan, DB Somasundaram, S Shanmugarama, S Aravindan Cancer Research 81 (13_Supplement), 3036-3036, 2021 | | 2021 |
